A new AIDS vaccine in Canada through animal testing

An AIDS vaccine has been in Canada adopted animal safety tests, the researchers are waiting for approval of the start in the United States for human testing.

Located in Canada East, Professor of Microbiology at the University of Western Ontario Kang Yung (Yong Kang, transliteration) has been working in this field for twenty years. He said that this vaccine enters human testing phase is a major milestone.

Kang Yung want to be able to quickly from the United States food and Drug Administration approved, to enable such AIDS vaccine began in humans for toxicity testing and two phases of clinical testing. If these three tests are successful, the vaccine will in the next ten years to apply.

According to the 2008 United Nations global AIDS report shows that in 2003 a total of seven-year global million people suffer from AIDS, of which two million deaths. In the past, there have been dozens of AIDS vaccines in animal tested, of which several have been tested in humans, but without success.

According to media reports, professor Kang Yung today's and Korea a pharmaceutical company in Canada to open branches in Ontario, funded laboratory experiments and vaccine commercialization. At present, the vaccine in the United States, Washington, d.c. region a laboratory production. Latest lab tests show that the animals the vaccine does not have any negative effects. If approved, 40 to 50 HIV virus tests of volunteers will be in the United States accepted the toxicity testing.